Neuro - Open Journal
Mohtashem Samsam, MD, PhD
Associate Professor of Medicine
Burnett School of Biomedical Sciences (BSBS)
College of Medicine, University of Central Florida
4000 Central Florida Blvd, HPA-II 320
Orlando, FL 32816, USA
• PhD in Neuroscience (1997-2002)
• Doctor of Medicine (MD) (1991-1996)
• Associate Degree of Radiology (1985-1987)
• Undergraduate studies: were done in Iran (1970-1982)
Positions and Professional Experiences
• Associate Professor of Medicine, (2013-present)
• Assistant Professor of Medicine, (2007-2013)
• Associate Professor of Medicine, (2006-present)
• Instructor of Anatomy, Clinical Neuroanatomy, Clinical Embryology, and Molecular Neuroscience (2004-2007)
• Associate Professor of Anatomy and Neuroscience (2003-2004)
• Academic senior post-doc in Developmental Neurobiology (1999-2002)
Igor Grachev, MD, PhD
Global Clinical Development Leader
TEVA Branded Pharmaceuticals
At present Igor Grachev, MD, PhD is a New Growth Franchise Global Head, Clinical, Medical and Drug Safety, Novartis Consumer Health, Inc, Parsippany, New Jersey. Earlier he was a Neurologist, Psychiatrist, Neuroscientist, Drug Developer, Translational Medicine/POC, Clinical Development, Medical Affairs and Imaging expert with over 20 years of extensive Pharma industry, academic and CRO biomedical research experience who has had roles of increasing responsibility and scope at MGH/Harvard Medical School, SUNY Upstate Medical University, Schering-Plough, Sanofi-Aventis, Merck, BioClinica, Merck Sharp & Dohme Corp, GE Healthcare, and Novartis Consumer Health. All his industry roles have involved the application of imaging, biomarkers and clinical neuroscience to drug development.
Joseph R. Shiber, MD, FACP, FACEP, FAAEM, FCCM
Departments of Emergency Medicine and Surgical Critical Care
Co-Director Neuroscience ICU
University of Florida – College of Medicine
Jacksonville, FL, USA
Dr. Shiber completed his undergraduate degree at Johns Hopkins University in 1990 and did additional graduate studies and research at JHU and JHMI. He graduated from medical school at University of Maryland in 1996. Dr. Shiber stayed at Maryland to be the first resident in the combined Emergency and Internal Medicine (EM-IM) program and later was chief resident. He completed fellowship in Critical Care at the R Adams Cowley Shock Trauma Center at the U. of MD. Previously he has been on faculty at East Carolina University where he was Program Director of the EM-IM residency and Medical Director of the Critical Care Consult service from 2001 to 2007. Dr. Shiber then joined the Baylor College of Medicine faculty, where he was the Director of Emergency Critical Care at Ben Taub General Hospital and an Intensivist at the Methodist Hospital of Houston. Since 2011, Dr. Shiber an Associate Professor of Emergency Medicine and Surgical Critical Care at U. FL College of Medicine – Jacksonville and the Co-Director of NSICU at U FL Health.
Dominique Durand, PhD
EL Lindseth Professor of Biomedical Engineering
Departments of Biomedical Engineering, Physiology, Biophysics and Neurosciences
Director, Neural Engineering Center
Editor in chief, Journal of Neural Engineering
Case Western Reserve University
Cleveland, OH, 44106, USA
Dr. Durand is the EL. Linsedth Professor of Biomedical Engineering Neurosciences, Physiology and Biophysics and Director of the Neural Engineering Center at Case Western Reserve University in Cleveland, Ohio. He received an engineering degree from Ecole Nationale Superieure dElectronique, Hydrolique, Informatique et Automatique de Toulouse, France in 1973. In 1974, he received a M.S. degree in Biomedical Engineering from Case Reserve University in Cleveland OH., worked several years at the Addiction Research Foundation of Toronto, Canada and in 1982 received a Ph.D. in Electrical Engineering from the University of Toronto in the Institute of Biomedical Engineering. He received an NSF Young Investigator Presidential Award as well as the Diekhoff and Wittke awards for graduate and undergraduate teaching and the Mortar board top-prof awards at Case Western Reserve University. He is an IEEE Fellow and also Fellow of the American Institute for Medical and Biomedical Engineering and Fellow of the Institute of Physics. He serves on five editorial boards of peer-reviewed scientific journals and he is the editor-in-chief and founding editor of the Journal of Neural Engineering. His research interests are in neural engineering and include computational neuroscience, neurophysiology and control of epilepsy, non-linear dynamics of neural systems, neural prostheses and applied magnetic and electrical field interactions with neural tissue. He has obtained funding for his research from the National Science Foundation, the National Institutes of Health and private foundations. He has published over 100 articles and he has consulted for many biotechnology companies and foundations.
Wen-Hai Chou, PhD
Department of Biological Sciences
School of Biomedical Sciences
Kent State University
41, Cunningham Hall
Kent, Ohio 44242, USA
Dr. Chou received his PhD from Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, Texas, USA. He completed his postdoctoral training at UCSF and later promoted as an Assistant Adjunct Professor, Department of Neurology, UCSF. He is now an Assistant Professor, Department of Biological Sciences, School of Biomedical Sciences, Kent State University, Ohio, USA.
His current research interest focuses on the roles of PKC isozymes and lipocalin-2 in Stroke-reperfusion injury using mouse genetics, experimental stroke models, and Chemical-genetics approaches.
Yunlei Yang, PhD, MD
Department of Neuroscience and Physiology
State University of New York Upstate Medical University
Syracuse, New York, USA
• Xinxiang Medical College, China , MD, (1997), Medicine
• Huazhong University of Sci and Tech., China , MS, (2000), Medicine
• Institute of Neuroscience, CAS, China, PhD, (2003), Neuroscience
• The Rockefeller University, New York, NY , Post PhD, (2003-2006), Neuroscience
• Mount Sinai School of Medicine, New York, NY, Post PhD, (2006-2009), Neurology
Positions and Employment
• (2009-2012) Research Specialist, Janelia Farm Research Campus, HHMI
• (2012-2014) Principal Investigator and Assistant Professor, Neuroscience and Physiology, Upstate Medical University of SUNY
Antonios Kerasnoudis, MD, PhD
St. Luke's Hospital
Ethnikis Antistasis 18, Serres
Dr. Kerasnoudis was born in Serres, Greece in 1983. In 2007 he graduated from the Medical School of the Aristotle University in Thessaloniki Greece.In 2009 he began his neurological residency in the Department of Neurology of the St.Josef Hospital Ruhr University Bochum in Germany which he completed at the end of 2013. He is board certified for electromyography neuromuscular ultrasound and extracranial intracranial Doppler ultrasound from the German and European Neurosonology Society.His clinical and research work focuses on the applications of ultrasound in clinical practice.
Dr. Kerasnoudis is the principal investigator of various nerve ultrasound studies on immune mediated neuropathies. His main scientific contributions are the detection of possible distribution patterns of pathological nerve ultrasound changes in immunemediated neuropathies such as the Guillain Barre syndrome (GBS) the multifocal motor neuropathy (MMN) and the chronic inflammatory demyelinating polyneuropathy (CIDP). His nerve ultrasound group based in Bochum Germany and Greece introduced for the first time in the literature a novel ultrasound score Bochum Ultrasound Score, allowing the differentiation of the CIDP from GBS in the acutesubacute phase. On March 2014 he won in Berlin the Young Investigator Award from the International Federation of Clinical Neurophysiology, IFCN for his scientific work and publications on neuromuscular ultrasound.
Dr. Kerasnoudis is co author of three books on neuromuscular ultrasound and author of many peer reviewed original articles. He is member of the German and Greek Neurological Society and enlisted in the editorial board and reviewer list of several journals of international repute
Xiaoyun Liang, PhD
Florey Institute of Neuroscience and Mental Health
The University of Melbourne
245 Burgundy Street
Heidelberg, 3084, Australia
Dr. Liang is a Magnetic Resonance (MR) physicist in The Florey Institute of Neuroscience and Mental Health, University of Melbourne. After obtaining his PhD degree from Southeast University in 2005, he joined Shanghai University as a lecturer. He finished his postdoctoral training in Brandeis (2007-2008) and Vanderbilt University (2008-2009) in USA. Since 2010, he moved to The Florey Institute of Neuroscience and Mental health as a senior research fellow. He is an expert in Magnetic Resonance Imaging (MRI), especially arterial spin labelling perfusion MRI. He is mainly focusing on advanced MRI development, with the aim of applying new methods, especially neuro imaging, to important clinical and neuro scientific problems, in particular in the field of epilepsy, stroke and Alzheimers disease.
Minho Moon, PhD
Department of Biochemistry
College of Medicine
Daejeon 302-718, Republic of Korea
Dr. Moon received his BSc in Biology from Kyung Hee University, Seoul, Korea. He obtained MS in Department of Anatomy and Neurobiology, Kyung Hee University School of Medicine and PhD in Department of Pharmacology, Kyung Hee University School of Medicine, and Seoul, Korea. He was appointed as an Instructor in Department of Psychiatry at Harvard Medical School in 2014. At present, he is an Associate Professor, in the Department of Biochemistry, at the College of Medicine, Konyang University, Republic of Korea.
Peter Schmidt, PhD
CIO and Vice President, Research and Professional Programs
National Parkinson Foundation
200 SE 1st St, Suite 800
Miami, FL 33131, USA
Dr. Schmidt joined National Parkinson Foundation (NPF) as Chief Information Officer (CIO) and Vice President, Research and Professional Programs in June 2009 where he is responsible for the Parkinson’s Outcomes Project, a longitudinal study of Parkinson’s disease to identify best practices in care to achieve optimal patient-reported and clinically measured outcomes. With over 15,000 clinical evaluations of over 7,000 patients, the Parkinson’s Outcomes Project is the largest clinical study of Parkinson’s disease ever conducted and includes the largest set of patient-reported outcome measures ever collected in a prospective study. Prior to NPF, Schmidt was an investment banker in Norwalk, CT., president a software company supporting chronic disease management, and COO of an on-line education joint venture of Oxford, Stanford, and Yale universities. He is an active member of several trade groups and is widely published in both scientific and trade journals on issues around medicine, health information technology and finance. Dr. Peter Schmidt earned his bachelor’s degree at Harvard University and was awarded an M.S. and Ph.D. from Cornell University, Sibley School of Mechanical Engineering where he studied gait and balance and total joint replacement. He completed a fellowship at the Hospital for Special Surgery in New York.
Dirk M. Hermann, MD
Chair for Vascular Neurology and Dementia
Department of Neurology
University Hospital Essen (AöR)
Dr. Dirk M Hermann studied medicine at the University of Gießen, Germany. After completing postdoctoral fellowships at the Max Planck Institutes in Munich and Cologne, he pursued his clinical training at University Hospitals in Tübingen and Zurich. He is now the Chair for Vascular Neurology and Dementia, at the University Hospital Essen, working on neurovascular remodelling and brain plasticity with special focus on ischaemic stroke.
Naeem Mahfooz, MD
University at Buffalo
Buffalo, NY, USA
Dr. Mahfooz graduated in 2006 from King Edward Medical College. He had done his Pediatric Internship and Residency from the State University of New York at Buffalo. Presently, he is doing his Pediatric Neurology Residency from University at Buffalo. He is currently involved in multiple research projects. His future goal is to become an academic Pediatric Epileptologist.
Rajendram V. Rajnarayanan, PhD
Assistant Professor of Pharmacology and Toxicology
Associate Director of IMSD-CLIMB program at UB
School of Medicine and Biomedical Sciences
State University of New York, Buffalo
3435 Main Street, Buffalo, NY 14214, USA
Our laboratory seeks to understand hormone-triggered nuclear receptor signaling. Nuclear receptors are associated with various diseases including diabetes and cancer and the availability of several high resolution structures of their ligand binding domains make them attractive targets for drug discovery. Eight of the top 100 prescription drugs (accounting for about US $9 billion in sales) target a nuclear receptor. However, these drugs can cause a variety of side effects and some patients develop drug resistance.
Tamoxifen, a drug designed to selectively target the nuclear estrogen receptor which is present in 70% of breast cancer patients, induces substantial regression of breast tumors and an increase in disease-free survival. Tamoxifen binds directly to the ligand binding domain of estrogen receptor and regulates estrogen-mediated growth of breast cancer cells. Tamoxifen mimics estrogen effects in other tissues thereby providing some beneficial effects including reduced risk of osteoporosis. However, breast cancers that initially respond well to tamoxifen tend to develop resistance and resume growth despite the continued presence of the antagonist.
We specifically focus on protein interactions that regulate estrogen signaling by binding to estrogen receptors. Our objective is to identify the estrogen receptor conformation-sensing regions of the interacting proteins and to discover potential small molecule sensors using state-of-the art bioinformatics and structure-based discovery tools and use them to generate a new breed of small molecular therapeutics for breast cancer therapy.
EDUCATION AND TRAINING:
• PhD, Chemistry, Tulane University (2001)
• MS, Chemistry, Indian Institute of Technology, Madras (1997)
• BS, Chemistry, Loyola College (1995)
• Postdoctoral Fellow, Proteomics and Nanotechnology, NIAMS, NIH
• Postdoctoral Fellow, Drug Discovery, Georgetown University Medical Center
Walaa F Alsanie, PhD
Department of Internal Medicine
Faculty of Medicine
Mr. Alsanie is a scientist at the Florey Institute of Neuro science and Mental Health, (The University of Melbourne, Australia) where he is currently finishing his PhD. Mr. Alsanie received his Masters degree with distinction in Laboratory Medicine from RMIT University, Australia. Mr. Alsanie completed his Bachelor degree in Laboratory Medicine at the faculty of Medicine, Um-Alqura University, Saudi Arabia. He then worked at the Faculty of Medicine, served as Lecturer in the department of Pharmacology, and a researcher at Taif Stem Cell Research Institute, Taif University, Saudi Arabia. Mr. Alsanie has authored and reviewed several publications in various journals. His publications reflect are research interests in pluripotent stem cells differentiation towards different neural lineages, for the purpose of transplantation, disease modelling and drug testing. Mr. Alsanie is a member in the Australas in Neuro science Society, Stem Cells Australia and the Australasian Society for Stem Cell Research.
Jaikishan Jayakumar, PhD
National Health and Medical research council (NHMRC)
Visual and Cognitive Neuroscience Laboratory
Department of Optometry and Vision Science
Melbourne Brain Centre, The University of Melbourne
7 Archibald chase, Point Cook, Victoria 3030
Dr. Jayakumar is a Research Fellow at the Department of Optometry and Vision Sciences, The University of Melbourne, Australia. After completing his BS in Optometry from the Birla Institute of Techonology and Science, India and Bachelor of Computer Applications from the University of Madras, India, Dr. Jayakumar completed his doctoral training (PhD) at the University of New South Wales, Australia. He is currently pursuing his research interests in visual neuroscience, studying the organization of the visual system at the University of Melbourne.
Parisa Farzanehfar, MD
Florey Institute of Neuroscience and Mental Health
University of Melbourne
Parkville, Vic 3010
Dr. Farzanehfar was graduated in 2010 from Isfahan University of Medical Sciences, Iran. After completing her medicine studies, she joined the Florey Institute of Neuroscience and Mental Health, Melbourne, Australia in 2012 to start her PhD in neuroscience. She is currently working on adult midbrain neurogenesis in context of Parkinsons disease.
Amit Modgil, PhD
Department of Neuroscience
School of Medicine
Boston, MA, USA
Dr. Modgil is a Postdoctoral fellow in the department of Neuroscience at Tufts university- School of medicine, Boston, MA. He has completed his doctoral training (PhD) in neurogenic hypertension from North Dakota state university, Fargo, ND. His doctoral research was focused on central blood pressure regulation and pathogenesis of hypertension to identify novel targets for the treatment of cardiovascular diseases. He has also worked at GSK, where he was part of the discovery and development of ion channel-targeting therapeutics team for the treatment of respiratory diseases. Dr. Modgil is a trained pharmacologist & electro physiologist with research experience in academia and industry. He has broad scientific knowledge in ion channel pharmacology and physiology. Utilizing electrophysiological techniques, his ongoing work is to examine the properties of recombinant and native extra synaptic GABAA receptors with special emphasis on α4 and δ subunits and their preferential targeting by endogenous and clinically relevant agents. His project is focused on fragile X syndrome in regards to altered activity of extra synaptic γ-amino butyric acid type A (GABAA) receptors that mediate tonic inhibition and impacts action potential firing frequency and are particularly sensitive to general anaesthetics and neurosteroids.
Roberto Maniglio, PhD
Associate Professor of Clinical Psychology
Department of Pedagogic, Psychological and Didactic Sciences
University of Salento
Piazzetta Tancredi, 73100 Lecce LE, Italy
Dr. Maniglio is an Associate Professor of Clinical Psychology. He is a Psychotherapist, a Criminologist and Forensic Psychopathologist, and a court-appointed expert. He teaches at the University of Salento, Lecce, Italy.
Ramesh K. Agarwal, PhD
William Palm Professor of Engineering
Department of Mechanical Engineering and Materials Science
Campus Box 1185
St. Louis, MO 63130-4899, USA
Dr. Agarwal is the William Palm Professor of Engineering in the Department of Mechanical Engineering and Materials Science at Washington University in St. Louis. From 1994 to 2001, he was the Sam Bloomfield Distinguished Professor and Executive Director of the National Institute for Aviation Research at Wichita State University in Kansas. From 1978 to 1994, he was the Program Director and McDonnell Douglas Fellow at McDonnell Douglas Research Laboratories in St. Louis. Dr. Agarwal received PhD in Aeronautical Sciences from Stanford University in 1975, MS in Aeronautical Engineering from the University of Minnesota in 1969 and B.S. in Mechanical Engineering from Indian Institute of Technology, Kharagpur, India in 1968. Over a period of 35+ years, he has worked in various areas of Computational Science and Engineering - Computational Fluid Dynamics (CFD), Computational Materials Science and Manufacturing, Computational Electromagnetics (CEM), Neuro-Computing, Control Theory and Systems, and Multidisciplinary Design and Optimization. He is the author and coauthor of over 460 publications. He has given many plenary, keynote and invited lectures at various national and international conferences worldwide in over fifty countries. Dr. Agarwal continues to serve on many academic, government, and industrial advisory committees.
Mayur S. Parmar, PhD
Department of Neurology
School of Medicine
University of Florida, Gainesville, FL, USA
Dr. Parmar is a postdoctoral associate in the Department of Neurology at the University of Florida, Gainesville, FL. Dr. Parmar earned a Ph.D. in Pharmacology and Toxicology from the Duquesne University, Pittsburgh, PA in 2014. Before joining Duquesne University, he completed his M.S in Pharmacology and Toxicology from the Long Island University, Brooklyn, NY in 2007. He did his bachelor of pharmacy from Sardar Patel University, Gujarat, India. Dr. Parmar’s current research is centered around validating putative genes that might be involved in the development of tauopathies, such as PSP and CBD.
Gokul Krishna, PhD
Department of Integrative Biology and Physiology
University of California Los Angeles
Los Angeles, USA
Dr. Gokul Krishna is a Postdoctoral Fellow at the Department of Integrative Biology and Physiology, University of California Los Angeles, Los Angeles. His research examines how the lifestyle factors influences neuroplasticity and consequently a variety of behaviors.
Livio Luongo, PhD
Department of Experimental Medicine
Division of Pharmacology
Second University of Naples, Italy
• (2008-2012, 2012, London) Neuropharmacology (Post-Doc), Second University of Naples, Italy. Wiliam Harvey, Queen Mary University, London
• 2008 (2006-2007 London) Pharmacology (PhD) Second University of Naples, Italy, King’s College, London
• (2004) Pharmacy University of Naples Federico II, Naples, Italy
Francesca Guida, PhD
Department of Experimental Medicine
Division of Pharmacology
Second University of Naples, Italy
• (2009-2015), Neuropharmacology (Post-Doc) Second University of Naples, Italy
• (2007-2009), Pharmacology (PhD) Second University of Naples, Italy, Kings College, London, UK
• (2005) Pharmacy, University of Naples Federico II, Italy
John F. Bebawy, MD
Department of Anesthesiology and Neurological Surgery
Northwestern University Feinberg School of Medicine
251 E. Huron St., Suite F5-704
Chicago, Illinois 60611, USA
Dr. Bebawy, MD is an Associate Professor of Anesthesiology & Neurological Surgery at Northwestern University. His clinical and research interests and expertise relate to Neuroanesthesia, with a focus on interventions that affect cerebral blood flow and cerebrovascular hemodynamics. Dr. Bebawy completed his Anesthesiology residency and Neurosurgical Anesthesiology fellowship training at Northwestern in 2008, where he is currentlyfaculty, Associate Director of the Neurosurgical Anesthesiology Fellowship Program, and Director of Neurosurgical Anesthesia Education. He is a member of many national and international societies for the advancement of Neurosurgical Anesthesiology, has published widely on various topics in the field, and has spoken at many meetings throughout the world on areas within his expertise. Dr. Bebawy is devoted and committed to the betterment of patient safety through individualized and compassionate clinical care, as well as through his contribution to the scientific community.
Shraddha D. Rege
University of California, Los Angeles, USA
Shraddha D. Rege is a postdoctoral fellow studying the molecular mechanisms of neuroplasticity and repair following traumatic brain injury at University of California-Los Angeles. She has her PhD in Molecular & Biochemical Nutrition from Auburn University, AL. Her research focused on identifying the links between obesity associated insulin resistance and Alzheimer’s disease (AD), as well as elucidating the potential role of bioactive compounds against oxidative stress and memory loss in AD. She has published over 8 peer-reviewed manuscripts including 5 first author manuscripts and is a member of Society for Neuroscience.